Rick E. Winningham - 20 May 2024 Form 4 Insider Report for Theravance Biopharma, Inc. (TBPH)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Brett A. Grimaud, Attorney-in-Fact
Issuer symbol
TBPH
Transactions as of
20 May 2024
Transactions value $
-$145,573
Form type
4
Filing time
22 May 2024, 18:10:21 UTC
Previous filing
17 May 2024
Next filing
06 Aug 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TBPH Ordinary Shares Tax liability -$145,572 -15,997 -0.86% $9.1 1,836,644 20 May 2024 Direct F1
holding TBPH Ordinary Shares 3,900 20 May 2024 As Custodian
holding TBPH Ordinary Shares 92,567 20 May 2024 By Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.